New RA drug GS-0272 enters early safety testing
NCT ID NCT06031415
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This early-stage study tests a new drug called GS-0272 in about 55 adults with rheumatoid arthritis. The main goal is to check if the drug is safe and how the body processes it at different doses. Participants will receive either the study drug or a placebo, and researchers will monitor side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
1238 E. Arrow Hwy
Upland, California, 91786, United States
-
1600 Republic Parkway
Mesquite, Texas, 75150, United States
-
ARENSIA Exploratory Medicine LLC
Tbilisi, 0112, Georgia
-
Accurate Clinical Research, Inc.
Houston, Texas, 77089, United States
-
Ajou University Hospital
Suwon, 16499, South Korea
-
Altoona Center for Clinical Research
Duncansville, Pennsylvania, 16635, United States
-
Arizona Arthritis & Rheumatology Associates P.C.
Glendale, California, 85306, United States
-
Cambridge Clinical Research Centre, Rheumatology Research Unit - E6, Addenbrookes Hospital
Cambridge, CB2 0QQ, United Kingdom
-
Chungnam National University Hospital
Daejeon, 35015, South Korea
-
Clinical Research of West Florida, Inc.
Clearwater, Florida, 33765, United States
-
Greater Chicago Specialty Physicians/ Clinical Investigation Specialists
Niles, Illinois, 60714, United States
-
Greater Chicago Specialty Physicians/Clinical Investigation Specialists, Inc.
Schaumburg, Illinois, 60195, United States
-
IMSP Republican Clinical Hospital "Timofei Mosneaga", ARENSIA E.M.
Chisinau, MD-2025, Moldova
-
Jacksonville Center for Clinical Research
Jacksonville, Florida, 32216, United States
-
Kings College Hospital
London, SE5 9RS, United Kingdom
-
NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust
Southampton, SO16 6YD, United Kingdom
-
PA Regional Center for Arthritis and Osteoporosis Research
Wyomissing, Pennsylvania, 19610, United States
-
Precision Comprehensive Clinical Research Solutions
Colleyville, Texas, 76034, United States
-
Precision Comprehensive Clinical Research Solutions
Irving, Texas, 75061, United States
-
Seoul National University Hospital
Seoul, 110 744, South Korea
-
Simbec Research Limited
Merthyr Tydfil, CF48 4DR, United Kingdom
-
Stanford School of Medicine, Division of Immunology & Rheumatology
Palo Alto, California, 94304, United States
-
Summit Headlands LLC
Portland, Oregon, 97210, United States
-
University Hospitals Coventry & Warwickshire NHS Trust
Coventry, CV2 2DX, United Kingdom
Conditions
Explore the condition pages connected to this study.